Brain scan study seeks suicide risk biomarker
NCT ID NCT02811198
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked for biological markers of suicide risk in 97 adults with major depressive disorder. Researchers used brain scans to measure how participants respond to pain, reward, and attention. The goal was to find stable brain-based signs that could help identify those at higher risk for suicide.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a brain-based test to help identify people with depression who are at higher risk for suicide.
- What could go wrong
- This is an early observational study with only 97 participants. The findings may not apply to everyone and need much more testing before any practical use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sakina Rizvi
Toronto, Ontario, M5B1M8, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can peer mentors help gay men with HIV stay in care?
- Can a structured care pathway ease teen depression?
- Can a nasal spray break through tough depression?
- Could a new drug offer hope for Treatment-Resistant depression?
- Targeting depression: can MRI-Guided brain zaps rewire key circuits?
- Hope in action: peer support may curb suicide risk in youth facing psychosis